GMV The Future, page-2812

Fantastic find Galilee 13 Not just any old online journal but the most Prestigious one in its field ! "With an Impact factor of 42.778 (2019)"

Nature publishes the finest peer-reviewed research that drives ground-breaking discovery, and is read by thought-leaders and decision-makers around the World.

From Artical Published 7 Augest 2020 ( Nature.com )

So far, the FDA has already issued several EUAs for home monitoring devices (‘EUA home monitoring devices’) to address COVID-1915,16 (Fig. 1 and Box 1). For example, an EUA was issued to G Medical Innovations for its VSMS patch intended to be used by healthcare professionals for remote patient monitoring of the QT interval of an ECG17. It is intended for use on patients over the age of 18 with COVID-19 who have been treated in hospitals with drugs that can cause life-threatening arrhythmias17. The patch, worn on the patient’s upper left chest for up to 14 days, is linked to a smartphone, which then transmits the data to a call center, run by G Medical Innovations, for QT analysis. The clinical findings are compiled by a certified cardiographic technician and are subsequently sent to the doctor at the hospital17. It is also easily conceivable that similar devices could be deployed further. Indeed, in 2017, the VSMS patch received the CE mark — a precondition for bringing a device to market — in Europe for home use in patients17.

This can only help all off to a front "Pole position", in any sales & marketing that's already begun for the 5th gen { Gold Standard } Patch
compared to our competitors 3rd 4th gen soon to be out off date devices!